Citations

Clear

16280 citation(s) found for "Yu, David".

Long-term outcomes for low-grade intracranial ganglioglioma: 30-year experience from the Mayo Clinic
Compton, Julia, Laack, Nadia N., Eckel, Laurence J. , Schomas, David A., Meyer, Fredric B. , Giannini, Caterina

Mayo Clinic

Journal of Neurosurgery | September 7, 2012 | Volume: 117 | Issue: 5 | Pages: 825-830

10.3171/2012.7.jns111260 | PMID 22957524 Get It

Object Gangliogliomas comprise less than 1% of all brain tumors and occur most often in children. Therefore, there are a limited number of patients and data involving the use or role of adjuvant therapy after subtotal resections (STRs) of gangliogliomas. The objective of this study was to examine and review the Mayo Clinic experience of 88 patients with gangliogliomas, their follow-up, risk of recurrence, and the role of radiation therapy after STR or only biopsy. Methods Eighty-eight patients with gangliogliomas diagnosed between 1970 and 2007 were reviewed. Data on clinical outcomes and therapy received were analyzed. The Kaplan-Meier method was used to estimate progression-free survival (PFS) and overall survival. Results The median age at diagnosis was 19 years. The median potential follow-up as of June 2008 was 142 months (range 9–416 months). Fifteen-year overall survival was 94%, median PFS was 5.6 years, with a 10-year PFS rate of 37%. Progression-free survival was dramatically affected by extent of initial resection (p < 0.0001). Conclusions This single-institution retrospective series of patients with gangliogliomas is unique given its large cohort size with a long follow-up duration, and confirms the excellent long-term survival rate in this group. The study also shows the importance of resection extent on likelihood of recurrence. Patients with gangliogliomas who undergo STR or biopsy alone have poor PFS. Radiation therapy may delay time to progression in patients with unresectable disease.
Advancing Alzheimer's disease diagnosis, treatment, and care: Recommendations from the Ware Invitational Summit
Naylor, Mary D. , Karlawish, Jason , Arnold, Steven E. , Khachaturian, Ara S. , Khachaturian, Zaven S., Baumgart, Matthew, Banerjee, Sube , Beck, Cornelia, Blennow, Kaj , Brookmeyer, Ron , Brunden, Kurt R. , Buckwalter, Kathleen C., Comer, Meryl, Covinsky, Kenneth E. , Feinberg, Lynn Friss, Frisoni, Giovanni B. , Guimarães, Renato Maia, Gwyther, Lisa P., Hutton, Michael , Kawas, Claudia H. , Kent, David M. , Kuller, Lewis H. , Langa, Kenneth M. , Mahley, Robert W. , Maslow, Katie, Masters, Colin L. , Meier, Diane E. , Neumann, Peter J. , Paul, Steven M., Petersen, Ronald C. , Sager, Mark A., Sano, Mary , Schenk, Dale, Soares, Holly , Stahl, Sidney M., Stern, Yaakov , Weir, David R. , Trojanowski, John Q. , Frisoni, Giovanni B. , Lee, Virginia M.‐Y. , Green, Colin Richard , Hefti, Franz F. , Sperling, Reisa Anne , Deerlin, Vivianna M. Van , Wolk, David A. , Stern, Yaakov , Masters, Colin L , Kent, David M

Mayo Clinic

Alzheimer's & Dementia | September 7, 2012 | Volume: 8 | Issue: 5 | Pages: 445-452

10.1016/j.jalz.2012.08.001 | PMID 22959699 Get It

AbstractTo address the pending public health crisis due to Alzheimer's disease (AD) and related neurodegenerative disorders, the Marian S. Ware Alzheimer Program at the University of Pennsylvania held a meeting entitled “State of the Science Conference on the Advancement of Alzheimer's Diagnosis, Treatment and Care,” on June 21‐22, 2012. The meeting comprised four workgroups focusing on Biomarkers; Clinical Care and Health Services Research; Drug Development; and Health Economics, Policy, and Ethics. The workgroups shared, discussed, and compiled an integrated set of priorities, recommendations, and action plans, which are presented in this article.
Enhanced excitability of guinea pig inferior mesenteric ganglion neurons during and following recovery from chemical colitis
Linden, David R.

Mayo Clinic

American Journal of Physiology-Gastrointestinal and Liver Physiology | September 7, 2012 | Volume: 303 | Issue: 9 | Pages: G1067-G1075

10.1152/ajpgi.00226.2012 | PMID 22961805 Get It

Postganglionic sympathetic neurons in the prevertebral ganglia (PVG) provide ongoing inhibitory tone to the gastrointestinal tract and receive innervation from mechanosensory intestinofugal afferent neurons primarily located in the colon and rectum. This study tests the hypothesis that colitis alters the excitability of PVG neurons. Intracellular recording techniques were used to evaluate changes in the electrical properties of inferior mesenteric ganglion (IMG) neurons in the trinitrobenzene sulfonic acid (TNBS) and acetic acid models of guinea pig colitis. Visceromotor IMG neurons were hyperexcitable 12 and 24 h, but not 6 h, post-TNBS during “acute” inflammation. Hyperexcitability persisted at 6 days post-TNBS during “chronic” inflammation, as well as at 56 days post-TNBS when colitis had resolved. In contrast, there was only a modest decrease in the current required to elicit an action potential at 24 h after acetic acid administration. Vasomotor neurons from inflamed preparations exhibited normal excitability. The excitatory effects of XE-991, a blocker of the channel that contributes to the M-type potassium current, and heteropodatoxin-2, a blocker of the channel that contributes to the A-type potassium current, were unchanged in TNBS-inflamed preparations, suggesting that these currents did not contribute to hyperexcitability. Riluzole, an inhibitor of persistent sodium currents, caused tonic visceromotor neurons to accommodate to sustained current pulses, regardless of the inflammatory state of the preparation, and restored a normal rheobase in neurons from TNBS-inflamed preparations but did not alter the rheobase of control preparations, suggesting that enhanced activity of voltage-gated sodium channels may contribute to colitis-induced hyperexcitability. Collectively, these data indicate that enhanced sympathetic drive as a result of hyperexcitable visceromotor neurons may contribute to small bowel dysfunction during colitis.
Phylogenetic and Physicochemical Analyses Enhance the Classification of Rare Nonsynonymous Single Nucleotide Variants in Type 1 and 2 Long-QT Syndrome
Giudicessi, John R. , Kapplinger, Jamie D., Tester, David J. , Alders, Mariëlle , Salisbury, Benjamin A. , Wilde, Arthur A.M. , Ackerman, Michael J.

Mayo Clinic

Circulation: Cardiovascular Genetics | September 5, 2012 | Volume: 5 | Issue: 5 | Pages: 519-528

10.1161/circgenetics.112.963785 | PMID 22949429 Get It

Background— Hundreds of nonsynonymous single nucleotide variants (nsSNVs) have been identified in the 2 most common long-QT syndrome-susceptibility genes ( KCNQ1 and KCNH2 ). Unfortunately, an ≈3% background rate of rare KCNQ1 and KCNH2 nsSNVs amongst healthy individuals complicates the ability to distinguish rare pathogenic mutations from similarly rare yet presumably innocuous variants. Methods and Results— In this study, 4 tools [(1) conservation across species, (2) Grantham values, (3) sorting intolerant from tolerant, and (4) polymorphism phenotyping] were used to predict pathogenic or benign status for nsSNVs identified across 388 clinically definite long-QT syndrome cases and 1344 ostensibly healthy controls. From these data, estimated predictive values were determined for each tool independently, in concert with previously published protein topology–derived estimated predictive values, and synergistically when ≥3 tools were in agreement. Overall, all 4 tools displayed a statistically significant ability to distinguish between case-derived and control-derived nsSNVs in KCNQ1 , whereas each tool, except Grantham values, displayed a similar ability to differentiate KCNH2 nsSNVs. Collectively, when at least 3 of the 4 tools agreed on the pathogenic status of C-terminal nsSNVs located outside the KCNH2/Kv11.1 cyclic nucleotide−binding domain, the topology-specific estimated predictive value improved from 56% to 91%. Conclusions— Although in silico prediction tools should not be used to predict independently the pathogenicity of a novel, rare nSNV, our results support the potential clinical use of the synergistic utility of these tools to enhance the classification of nsSNVs, particularly for Kv11.1’s difficult to interpret C-terminal region.
A Multifactorial Likelihood Model for MMR Gene Variant Classification Incorporating Probabilities Based on Sequence Bioinformatics and Tumor Characteristics: A Report from the Colon Cancer Family Registry
Thompson, Bryony A. , Goldgar, David E. , Paterson, Carol, Walters, Rhiannon, Arnold, Sven, Parsons, Michael T. , D., Walsh Michael, Gallinger, Steven , Haile, Robert W. , Jenkins, Mark A. , Lindor, Noralane M. , Thibodeau, Stephen N. , Registry, Colon Cancer Family, Young, Joanne , Buchanan, Daniel D. , Tavtigian, Sean V. , Spurdle, Amanda B. , Clendenning, Mark , Hopper, John L. , Marchand, Loı̈c Le , Newcomb, Polly A. , Registry, Colon Cancer Family, Buchanan, Daniel D , Parsons, Michael T , Spurdle, Amanda B , Jenkins, Mark A , Haile, Robert W

Mayo Clinic

Human Mutation | September 4, 2012 | Volume: 34 | Issue: 1 | Pages: 200-209

10.1002/humu.22213 | PMID 22949379 Get It

Skull Base Involvement by Acinic Cell Carcinoma of the Parotid Gland
Breen, Joseph J., Carlson, Matthew David, Link, Michael J. , Moore, Eric J. , Neff, Brian, Driscoll, Colin L. W., Neff, Brian A.

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | August 29, 2012 | Volume: 73 | Issue: 06 | Pages: 371-378

10.1055/s-0032-1322797 | PMID 24294553 Get It

Should neurointerventional fellowship training be suspended indefinitely?
Hirsch, Joshua A , Rasmussen, Peter A. , Hussain, Muhammad Shazam , Frei, Donald , Meyers, Phil M., Jabbour, Pascal , Gonzalez, L. Fernando , Turk, Aquilla S , Turner, Raymond D , Arthur, Adam S , Gupta, Rishi , Cloft, Harry J. , Fiorella, David , Woo, Henry Hyunshik , Hui, Ferdinand , Mocco, J , Arthur, Adam Stephen

Mayo Clinic

Journal of NeuroInterventional Surgery | August 29, 2012 | Volume: 4 | Issue: 5 | Pages: 315-318

10.1136/neurintsurg-2012-010471 | PMID 22933732 Get It

Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome
Hurley, Paula J. , Marchionni, Luigi , Simons, Brian W. , Ross, Ashley E. , Peskoe, Sarah B. , Miller, Rebecca M., Erho, Nicholas , Vergara, Ismael A. , Ghadessi, Mercedeh , Huang, Zhenhua , Gürel, Bora , Davicioni, Elai , Jenkins, Robert B. , Berman, David M. , Schaeffer, Edward M. , Park, Ben Ho , Platz, Elizabeth A. , Davicioni, Elai

Mayo Clinic

Proceedings of the National Academy of Sciences | August 27, 2012 | Volume: 109 | Issue: 37 | Pages: 14977-14982

10.1073/pnas.1203525109 | PMID 22927397 Get It

Prostate cancer is the second leading cause of cancer death among United States men. However, disease aggressiveness is varied, with low-grade disease often being indolent and high-grade cancer accounting for the greatest density of deaths. Outcomes are also disparate among men with high-grade prostate cancer, with upwards of 65% having disease recurrence even after primary treatment. Identification of men at risk for recurrence and elucidation of the molecular processes that drive their disease is paramount, as these men are the most likely to benefit from multimodal therapy. We previously showed that androgen-induced expression profiles in prostate development are reactivated in aggressive prostate cancers. Herein, we report the down-regulation of one such gene, Sparcl1 , a secreted protein, acidic and rich in cysteine (SPARC) family matricellular protein, during invasive phases of prostate development and regeneration. We further demonstrate a parallel process in prostate cancer, with decreased expression of SPARCL1 in high-grade/metastatic prostate cancer. Mechanistically, we demonstrate that SPARCL1 loss increases the migratory and invasive properties of prostate cancer cells through Ras homolog gene family, member C (RHOC), a known mediator of metastatic progression. By using models incorporating clinicopathologic parameters to predict prostate cancer recurrence after treatment, we show that SPARCL1 loss is a significant, independent prognostic marker of disease progression. Thus, SPARCL1 is a potent regulator of cell migration/invasion and its loss is independently associated with prostate cancer recurrence.
Healing of saccular aneurysms following platinum coil embolization: lack of improved efficacy with vitamin C supplementation
Yong-Hong, Ding, Rezek, Issa, Lewis, Debra A., Kallmes, David F. , Kadirvel, Ramanathan , Dai, Daying , Yong-Hong, Ding

Mayo Clinic

Journal of NeuroInterventional Surgery | August 23, 2012 | Volume: 5 | Issue: 6 | Pages: 591-596

10.1136/neurintsurg-2012-010421 | PMID 22914744 Get It

Background and purpose To test the hypothesis that systemic administration of vitamin C, through its action of stimulating collagen synthesis and crosslinking, would decrease the recurrence and improve the occlusion of experimental aneurysms treated with platinum coils. Methods Experimental aneurysms were created in female rabbits and were embolized with platinum coils (>30% packing density). The animals were divided into three groups: group 1 (n=6) rabbits served as controls, group 2 (n=5) rabbits were fed with a vitamin C supplemented feed and group 3 (n=8) rabbits were medicated with vitamin C pills. Digital subtraction angiography was used to evaluate stability after embolization. Subjects were euthanized at 12 weeks after coil implantation, and serum vitamin C levels were then measured. Histological samples were examined with a grading system (range 0–12) based on the neck and dome features. Masson Trichrome staining was used to evaluate collagen deposition. Parametric data were analyzed with one way analysis of variance and non-parametric data were examined using a Kruskal–Wallis test. Results There were no significant differences between groups in mean aneurysm size. Mean serum vitamin C concentration was significantly higher in group 3 and group 2 compared with group 1, while vitamin C levels between group 2 and group 3 were statistically comparable. Coil compaction was noted in one of six subjects in group 1 and in three of eight subjects in group 3. All of the remaining aneurysms in the test and control groups showed stable occlusion. There were no significant differences in histological scores or collagen deposition among groups. Conclusions Vitamin C supplementation following platinum coil embolization does not demonstrate improvement of long term occlusion rates of aneurysms.
Subjective cognitive impairment
Knopman, David S.

Mayo Clinic

Neurology | August 23, 2012 | Volume: 79 | Issue: 13 | Pages: 1308-1309

10.1212/wnl.0b013e31826c1bd1 | PMID 22914836 Get It